This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Aldose Reductase
From Proteopedia
(Difference between revisions)
| Line 19: | Line 19: | ||
</StructureSection> | </StructureSection> | ||
| - | == 3D Structures of aldose reductase == | ||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *Aldose Reductase | ||
| - | |||
| - | **[[1abn]], [[1ads]], [[3q65]] - hAldR +NADP – human<br /> | ||
| - | **[[2alr]] – hAldR <br /> | ||
| - | **[[1xgd]] – hAldR (mutant)<br /> | ||
| - | **[[3q67]] – hAldR (mutant)+NADP<br /> | ||
| - | **[[3afm]] – SsAldR A1-R – ''Sphingomonas sp.''<br /> | ||
| - | **[[3afn]] - SsAldR A1-R+NADP<br /> | ||
| - | **[[1dla]], [[1cwn]] – pAldR - pig<br /> | ||
| - | **[[1ah4]], [[3cv7]] - pAldR+NADP<br /> | ||
| - | **[[1hqt]] – pAldR (mutant) + NADP<br /> | ||
| - | **[[3krb]] – AldR+NADP – ''Ghiardia lamblia''<br /> | ||
| - | **[[2bgq]] – bAldR - barley<br /> | ||
| - | **[[2bgs]] - bAldR+NADP<br /> | ||
| - | **[[4gca]] – AldR – mouse<br /> | ||
| - | **[[5jh1]], [[5jgy]] – maAldR – maize<br /> | ||
| - | **[[5jgw]] – maAldR + NADP<br /> | ||
| - | **[[5zci]] – DnAldR – ''Debaryomyces nepalensis''<br /> | ||
| - | **[[5zcm]] – DnAldR + NADP<br /> | ||
| - | |||
| - | *Aldose Reductase+inhibitors | ||
| - | |||
| - | **[[3ghr]], [[3ghs]], [[3ght]], [[3ghu]], [[2r24]], [[2pzn]], [[3g5e]], [[2qxw]], [[2iki]], [[2i16]], [[2i17]], [[1t40]], [[1t41]], [[1us0]], [[1el3]], [[3t42]], [[4ys1]], [[4rpq]], [[4qr6]], [[4qbx]], [[4q7b]], [[2pev]], [[2pf8]], [[2pfh]], [[4puw]], [[4puu]] - hAldR +NADP+IDD inhibitors<br /> | ||
| - | **[[3onb]], [[3onc]], [[2pdk]], [[1az1]] – hAldR (mutant) +NADP+IDD inhibitor<br /> | ||
| - | **[[3u2c]] - hAldR +NADP+ NSAID inhibitor<br /> | ||
| - | **[[3bcj]], [[1x97]], [[1x98]], [[1pwm]], [[1ef3]], [[2pd5]], [[2dux]], [[2duz]], [[2dv0]], [[2fz8]], [[2fz9]], [[2hv5]], [[2hvn]], [[2hvo]], [[1mar]], [[2fzb]], [[2fzd]], [[1z3n]], [[1pwl]], [[1iei]], [[4jir]] - hAldR+NADP+inhibitor for diabetic treatment<br /> | ||
| - | **[[1z89]], [[1z8a]] - hAldR+NADP+sulfonyl-pyridazinone<br /> | ||
| - | **[[5ha7]] – hAldR (mutant) +NADP+pyrimidine inhibitor<br /> | ||
| - | **[[4yu1]], [[4prt]], [[4prr]], [[4pr4]], [[4nkc]] – hAldR +NADP+ diphenyl inhibitor<br /> | ||
| - | **[[2pdg]], [[2pdh]], [[4xzi]], [[4xzh]] - hAldR+NADP+uracil inhibitor<br /> | ||
| - | **[[1x96]], [[2acs]], [[2acu]] - hAldR+NADP+citrate<br /> | ||
| - | **[[2acq]] - hAldR +NADP+glucose phosphate<br /> | ||
| - | **[[2acr]] - hAldR +NADP+cacodylate<br /> | ||
| - | **[[2ikg]], [[2ikh]], [[2ikj]], [[3v35]] - hAldR+NADP+nitro-substituted inhibitor<br /> | ||
| - | **[[3v36]] - hAldR+NADP+ glyceraldehyde + azine<br /> | ||
| - | **[[2nvc]], [[2nvd]] - hAldR+NADP+isothiazole inhibitor<br /> | ||
| - | **[[3p2v]] - hAldR+NADP+ benzothiazepine inhibitor<br /> | ||
| - | **[[2ipw]], [[2iq0]], [[2iqd]], [[2isf]], [[2ine]], [[2inz]], [[2is7]] - hAldR+NADP+ acid<br /> | ||
| - | **[[2f2k]] - hAldR+NADP+DEG<br /> | ||
| - | **[[2pdn]], [[2pdq]] – hAldR (mutant)+NADP+uracil inhibitor<br /> | ||
| - | **[[2pdb]], [[2pdf]], [[2pdi]], [[2pdm]], [[2pdx]], [[3len]], [[3m0i]], [[3mb9]], [[2pd9]], [[2pdw]], [[2pdy]], [[2agt]], [[2pdl]] – hAldR (mutant)+NADP+inhibitor for diabetic treatment<br /> | ||
| - | **[[1az2]] - hAldR (mutant)+NADP+citrate<br /> | ||
| - | **[[3lbo]], [[3ld5]], [[3lql]], [[3lz5]], [[2pdc]], [[3lep]], [[3lqg]], [[3lz3]], [[3m4h]], [[2pdj]], [[2pdp]], [[2pdu]], [[3m64]], [[3mc5]] - hAldR (mutant)+IDD inhibitors<br /> | ||
| - | **[[3dn5]] – hAldR+NADP+biaryl inhibitor<br /> | ||
| - | **[[3rx2]], [[3rx3]], [[3rx4]], [[3s3g]] - hAldR+NADP+ sulindac inhibitor<br /> | ||
| - | **[[4igs]] - hAldR+NADP+ polyfluorinated inhibitor<br /> | ||
| - | **[[4lau]], [[4laz]], [[4lb3]], [[4lb4]], [[4lbr]], [[4lbs]], [[4qxi]] - hAldR+NADP+ carbamoyl inhibitor<br /> | ||
| - | **[[4qx4]] - hAldR+NADP+ mercaptotriazinoindole inhibitor<br /> | ||
| - | **[[3fx4]] – pAldR+NADP+thiazolidine derivative <br /> | ||
| - | **[[1eko]], [[1ah0]], [[3h4g]], [[1ah3]], [[1ae4]] - pAldR+NADP+IDD inhibitor<br /> | ||
| - | **[[2vdg]] – bAldR+NADP+butanol <br /> | ||
| - | **[[5jh2]] – maAldR + adenosine diphosphate <br /> | ||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
References
- ↑ Rondeau JM, Tete-Favier F, Podjarny A, Reymann JM, Barth P, Biellmann JF, Moras D. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase. Nature. 1992 Jan 30;355(6359):469-72. PMID:1734286 doi:http://dx.doi.org/10.1038/355469a0
- ↑ Wilson DK, Bohren KM, Gabbay KH, Quiocho FA. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science. 1992 Jul 3;257(5066):81-4. PMID:1621098
